.svg){kind=icon}
Oncology Expertise for Development Success
Hear from IQVIA oncology experts on the topics, trends and scientific developments that are relevant to your clinical development program.
Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
Latest article published on Nature Reviews Drug Discovery, providing an update to previous PD-1/PD-L1 analyses.
Global Oncology Trends 2022
This annual trend report on Global Oncology from the IQVIA Institute examines those novel medicines and the clusters of research which promise a continuing sequence of breakthroughs in the decade to come. The report explores the impact of COVID-19 disruptions and the longer-term trends in the use of cancer medicines as well as the drivers of spending globally, in key geographies, by tumor type, and for specific types of oncology drugs.
Advancing Pediatric Cancer Research
Impact and Implications of the RACE for Children Act.
Evolving Oncology Endpoints
This report examines trends in new and evolving oncology endpoints being studied in clinical trials.